Drug Type Small molecule drug |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (Japan) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Arterial Hypertension | Preclinical | Japan | 01 Feb 2025 | |
Acute decompensated heart failure | Preclinical | Japan | 16 Jun 2023 | |
Heart failure with normal ejection fraction | Preclinical | Japan | 16 Jun 2023 | |
Heart failure with reduced ejection fraction | Preclinical | Japan | 16 Jun 2023 |